Platelet aggregating material from equine arterial tissue

Title: Platelet aggregating material from equine arterial tissue

Full Record
Other Related Research

Abstract

Novel hemostatic agent comprises equine arterial fibrillar collagen in a carrier. The agent is useful for the aggregation of platelets for clinical diagnostic tests and for the clotting of blood, such as for controlling bleeding in warm blooded species. The fibrillar collagen is obtained by extracting homogenized equine arterial tissue with aqueous solutions followed by extensive dialysis.

Inventors:

Schneider, Morris D ^[1]

Knoxville, TN

Issue Date:: 1983-02-22

OSTI Identifier:: 864499

Patent Number(s):: 4374830

Application Number:: 06/292,201

Assignee:: Research Corp. (New York, NY)

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: platelet; aggregating; material; equine; arterial; tissue; novel; hemostatic; agent; comprises; fibrillar; collagen; carrier; useful; aggregation; platelets; clinical; diagnostic; tests; clotting; blood; controlling; bleeding; warm; blooded; species; obtained; extracting; homogenized; aqueous; solutions; followed; extensive; dialysis; aggregating material; platelet aggregating; aqueous solution; aqueous solutions; agent comprises; arterial tissue; equine arterial; /514/424/435/530/

Citation Formats


                    Schneider, Morris D. Platelet aggregating material from equine arterial tissue.  United States: N. p., 1983. 
        Web.

Copy to clipboard


                    Schneider, Morris D. Platelet aggregating material from equine arterial tissue.  United States.

Copy to clipboard


                    Schneider, Morris D. Tue .  
        "Platelet aggregating material from equine arterial tissue".  United States.  https://www.osti.gov/servlets/purl/864499.

Copy to clipboard


                    
@article{osti_864499,

  title        = {Platelet aggregating material from equine arterial tissue},

  author       = {Schneider, Morris D},

  abstractNote = {Novel hemostatic agent comprises equine arterial fibrillar collagen in a carrier. The agent is useful for the aggregation of platelets for clinical diagnostic tests and for the clotting of blood, such as for controlling bleeding in warm blooded species. The fibrillar collagen is obtained by extracting homogenized equine arterial tissue with aqueous solutions followed by extensive dialysis.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {1983},

  month        = {2}

}

Copy to clipboard

Patent:

View Patent

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE Patents and OSTI.GOV collections:

Acid soluble platelet aggregating material isolated from human umbilical cord

Patent Schneider, Morris D [Knoxville, TN]

Acid soluble, pepsin sensitive platelet aggregating material isolated from human umbilical cord tissue by extraction with dilute aqueous acid, method of isolation and use to control bleeding.
Full Text Available
Synthetic aggregate compositions derived from spent bed materials from fluidized bed combustion and fly ash

Patent Boyle, Michael J [Aston, PA]

Cementitious compositions useful as lightweight aggregates are formed from a blend of spent bed material from fluidized bed combustion and fly ash. The proportions of the blend are chosen so that ensuing reactions eliminate undesirable constituents. The blend is then mixed with water and formed into a shaped article. The shaped article is preferably either a pellet or a "brick" shape that is later crushed. The shaped articles are cured at ambient temperature while saturated with water. It has been found that if used sufficiently, the resulting aggregate will exhibit minimal dimensional change over time. The aggregate can be certifiedmore »« less
Full Text Available
Combinational pixel-by-pixel and object-level classifying, segmenting, and agglomerating in performing quantitative image analysis that distinguishes between healthy non-cancerous and cancerous cell nuclei and delineates nuclear, cytoplasm, and stromal material objects from stained biological tissue materials

Patent Boucheron, Laura E

Quantitative object and spatial arrangement-level analysis of tissue are detailed using expert (pathologist) input to guide the classification process. A two-step method is disclosed for imaging tissue, by classifying one or more biological materials, e.g. nuclei, cytoplasm, and stroma, in the tissue into one or more identified classes on a pixel-by-pixel basis, and segmenting the identified classes to agglomerate one or more sets of identified pixels into segmented regions. Typically, the one or more biological materials comprises nuclear material, cytoplasm material, and stromal material. The method further allows a user to markup the image subsequent to the classification to re-classifymore »« less
Full Text Available
Method for the production of cementitious compositions and aggregate derivatives from said compositions, and cementitious compositions and aggregates produced thereby

Patent Minnick, L John [Box 271, Plymouth Meeting, PA 19462]

The present invention relates to a method for preparing synthetic shaped cementitious compositions having high quality even without the addition of high energy binders, such as portland cement, through the use of the spent residue from a fluidized combustion bed of the type wherein limestone particles are suspended in a fluidized medium and sulfur oxides are captured, and pulverized coal fly ash.
Full Text Available
Method for the production of cementitious compositions and aggregate derivatives from said compositions

Patent Minnick, L John [Box 271, Plymouth Meeting, PA 19462]

Method for the production of cementitious compositions and aggregate derivatives of said compositions, and cementitious compositions and aggregates produced by said method, wherein fluidized bed combustion residue and pozzolanic material, such as pulverized coal combustion system fly ash, are incorporated in a cementitious mix. The mix is cast into desired shape and cured. If desired, the shape may then be crushed so as to result in a fluidized bed combustion residue-fly ash aggregate material or the shape may be used by itself.
Full Text Available

Similar Records